Hologic
Latest Startup Investment Opportunities:
HOLX
, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the availability of its next generation NovaSure system -- a 90-second, minimally-invasive, outpatient treatment for women suffering from excessive menstrual bleeding.
The next generation NovaSure system is designed to offer the same customized technology as Hologic's current NovaSure system trusted by physicians across the United States, but with even more control and confidence for the physician and more comfort for the patient.
"We have worked closely with our customers to incorporate a number of physician and patient-focused enhancements resulting in a device designed to offer more leverage and control with significantly less manipulation. This next generation system is designed to provide the physician with improved procedure efficiency and offer the patient even greater comfort," said Steve Williamson, Senior Vice President and General Manager, Hologic GYN Surgical Products. "More than one million women have been treated with the NovaSure procedure. We believe the new NovaSure enhancements will expand the number of women who are offered the NovaSure procedure as a solution for excessive menstrual bleeding."
Loading...
Loading...
HOLXHologic Inc
$63.531.54%
Edge Rankings
Momentum
25.47
Growth
42.03
Quality
59.28
Value
10.20
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in